E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Bewersdorf, Jan Philipp, Stahl, Maximilian, Taylor, Justin · Leukemia · 2023